A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date1/08/0525/12/07